Upon associating with target membranes, SNX PX-BAR domains drive membrane tubulation for tubule-based sorting (9) .
Arfaptins (Arfaptin-1 and Arfaptin-2) are canonical BAR domain−containing proteins with no additional lipid-binding modules.
Arfaptin-2 alone can deform liposomes into tubules in vitro (2) and can bind to the Arf and Rac GTPases (10,11), suggesting that membrane remodeling induced by Arfaptin-2 can be modulated by these GTPases. Based on the crystal structure of the Arfaptin-2 BAR domain in complex with Rac1, Rac1 binds to the concave face of the Arfaptin-2 BAR homodimer, likely interfering with membrane association of the BAR domain (12) . Moreover, Arf1/Arf6 and Rac1 bind to the Arfaptin-2 BAR domain in a mutually exclusive manner (12) . However, the molecular basis for the possible cross-talk between Arf and Rac1 GTPases mediated by Arfaptin-2 remains to be elucidated.
Arfaptins are known to localize to the Golgi region when exogenously expressed in cells (2, 13) . We have recently shown that both Arfaptin-1 and Arfptin-2 interact not only with Arf GTPases but also with Arf-like 1 (Arl1), yet are recruited to trans-Golgi membranes through interaction with Arl1, rather than with the Arf GTPases (14) . Arfaptin-2 colocalizes with Arl1 at dynamic vesicular and tubular structures emanating from the Golgi, suggesting that Arl1 may regulate Arfaptin-mediated membrane deformation at the trans-Golgi (14) . Here, we report the crystal structure of the BAR domain of Arfaptin-2 in complex with Arl1; in the present study, we selected Arfaptin-2, because in our previous study we characterized more extensively the interaction of Arfaptin-2 with For the SPR experiments, cDNA fragments for human Arl1(Q71L) (residues 14−181) and full-length human Rac1 (1−192) harboring a G12V mutation (17) kind gift from Manabu Negishi, Kyoto University) were cloned into the expression vector pET28a (Novagen).
The proteins were overexpressed in the E. coli Crystallization -Purified Arl1-GppNHp and Arfaptin-2 BAR were concentrated using Amicon Ultra 15 10,000 MWCO (Millipore) in 10 mM Tris-HCl, pH 7.5, 300 mM NaCl, 1 mM MgCl 2 , and mixed to yield final concentrations of 0.7 and 1.9 mg/ml, respectively (1:2 molar ratio). The crystallization condition was first screened using a protein crystallization system (18) and subsequently refined. was performed using an A1R-MP confocal microscope (Nikon) as described previously (14) . 
RESULTS

Crystal
Interaction involving a charged residue in the
Arl1 N-terminal region stabilizes the Arl1-BAR complex -Although the above pull-down assay ( Fig. 2A) indicated that Glu17 of Arl1 is not critical for its interaction with Arfaptin-2, we were still interested in potential ionic interactions involving the N-terminal charged residues of Arl1, because these residues are conserved between Arl1 and Arf1−Arf6 (Supplemental Fig. S1A ). Therefore, we focused on the interaction between Arg19 of Arl1 and Asp220 of Arfaptin-2 suggested by the crystal structure ( Fig. 1D, E) . As shown in Fig. 5A , introduction of an R19A mutation into Arl1(Q71L) greatly diminished its binding to GST-Arfaptin-2 (compare lanes 11 and 13).
Furthermore, substitution of both Arg19 and
Glu17 by alanine almost completely abrogated the interaction of Arl1(Q71L) with Arfaptin-2 (lane 14). We then turned to Asp220 of Arfaptin-2, whose side chain potentially interacts with the Arg19 side chain of Arl1 (Fig.   1D , E). As expected, D220A mutation of Arfaptin-2 abolished its interaction with Arl1(Q71L) (Fig. 5B, compare lanes 3 and 4) . The concave face of SNX9 PX-BAR engaged in membrane binding is predominantly positively charged (Fig. 7C) . SNX9 PX-BAR is known to effectively tubulate phosphoinositide-containing liposomes (7, 31) .
Similarly, the concave surface of Arl1-Arfaptin-2 BAR is positively charged, though less extensively (Fig. 7D) . Thus, like SNX9 PX-BAR, the Arl1-Arfaptin-2 BAR complex appears to be suitable for associating with negatively charged membranes.
As demonstrated by cryo-EM of the In contrast, the α 2 and α3 helices of Arfaptin-2 BAR are oriented at an oblique angle to the interswitch β strands (Fig. 8B) , enabling simultaneous membrane association of Arl1 and Arfaptin-2 BAR.
When the structure of the Arl1-BAR complex is superimposed on that of the Arl1-GRIP complex, the Arl1 effector helices are nearly perpendicular to one another (Fig. 8A,   B ). Nevertheless, the key residues responsible for Arl1 binding of the Arfaptin-2 BAR and golgin-245 GRIP domains (Phe285 and Tyr2177, respectively) occupy nearly the same position in the hydrophobic pocket of Arl1 (Fig. 8C ).
Within the Arl1 hydrophobic pocket, there is a significant shift in the side chain of Tyr81 between the Arl1-BAR and Arl1-GRIP complexes, while the other residues overlap well.
In its complex with golgin-245 GRIP, Tyr81 of Arl1 makes a hydrogen bond with the side chain of the key Tyr2177 residue of golgin-245 (Fig.   8C ). This hydrogen bond is critical for the Arl1-GRIP interaction, since both the Y81A and Y81F mutations of Arl1 abrogate Arl1 binding to golgin-245 (Fig. 4A) . Thus, within the hydrophobic pocket, the hydrogen bond appears to determine the specificity of the Arl1-GRIP interaction. On the other hand, the hydroxyl group at this position is dispensable, but the bulky hydrophobic side chain is required to maintain the Arl1-BAR interaction, since the Y81A mutation but not the Y81F mutation abolished Arl1 binding to Arfaptin-2 (Fig. 4A ).
The residues in the Arl1 interswitch region that interact with golgin-245 GRIP are limited to the region around the hydrophobic triad patch (Fig. 8A) . This renders Phe51 of Arl1 indispensable for binding to the GRIP domain, as demonstrated by the failure of Arl1 F51A mutant to bind (Fig. 4A) . In contrast, the same Arl1 mutation has no obvious effect on Arfaptin-2 binding, due to the extensive hydrophobic interactions not only in the hydrophobic triad patch, but also throughout the entire Arl1 interswitch region (Fig. 8B) . Our SPR data also revealed that Arl1 
